Invest now
Sandu Pharmaceuticals share price
Balanced risk
You have to be logged in to add this to Watchlist.- ₹36.46(-0.27%)October 9, 2026 15:50:12 PM IST
- NSE
- BSE
- Vol : 6.83 K (NSE + BSE)Last 20 day avg : 1.49 K
Sandu Pharmaceuticals is trading -0.27% lower at Rs 36.46 as compared to its last closing price. Sandu Pharmaceuticals has been trading in the price range of 37.29 & 34.00. The company posted a net profit of 0.23 Crores in its last quarter.Listed peers of Sandu Pharmaceuticals include Sun Pharmaceutical Industries (0.25%), Divi's Laboratories (-0.67%), Torrent Pharmaceuticals (-0.32%).The Mutual Fund holding in Sandu Pharmaceuticals was at -% in . The MF holding has - from the last quarter. The FII holding in Sandu Pharmaceuticals was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 09 Oct 2026, 07:49 PM IST
- BetaHigh volatility1.27Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.01The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldHigher than industry2.72Annual dividends as a percentage of the stock price.
- PEG RatioIndicates overvaluation4.37The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Sandu Pharmaceuticals Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,756.90 | 0.25 | 4,21,529.23 | 36.56 | 5.28 | - | - |
| Divi's Laboratories | 9,326.00 | -0.67 | 2,47,575.99 | 94.31 | 14.76 | - | - |
| Torrent Pharmaceuticals | 4,660.00 | -0.32 | 1,77,245.08 | 75.82 | 20.03 | - | - |
| Zydus Lifesciences | 1,115.10 | -0.01 | 1,11,231.65 | 20.74 | 4.15 | - | - |
| Cipla | 1,303.30 | -0.13 | 1,05,288.19 | 26.55 | 3.2 | - | - |
Sandu Pharmaceuticals Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-08-11 | Quarterly Results |
| 2026-07-11 | Others |
| 2026-05-05 | Audited Results & Final Dividend |
| 2026-02-06 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
About the company Sandu Pharmaceuticals
- IndustryBiotechnology & Drugs
- ISININE751D01014
- BSE Code524703
- NSE Code
Sandu Pharmaceuticals Limited is an India-based company, which is mainly engaged in the business of manufacturing and trading of ayurvedic medicines under the brand name, SANDU. The Company's product category includes digestive health, immunity, muscle and bone health, respiratory health, wellness, and others. Its digestive health products focus on constipation, hyperacidity, indigestion and flatulence, and loose motions, among others. Its wellness products cover female wellness, male wellness and mother and child. Its respiratory health products focus on respiratory health, asthma, and cold and cough. Its ayurveda category includes herbs, panchakarma, dincharya, rutucharya, ahar vihar, arogyadarshika, prakruti and yoga. The Company also offers products, such as an immunity kit and a power herbs range. Its products are manufactured using in-house know-how supplied by Sandu Brothers Private Limited. The Company's products are sold through e-commerce marketplaces.
Sandu Pharmaceuticals Share Price FAQs
Sandu Pharmaceuticals is trading at 36.46 as on Fri Oct 09 2026 10:20:12. This is -0.27% lower as compared to its previous closing price of 36.56.
The market capitalization of Sandu Pharmaceuticals is 35.16 Cr as on Fri Oct 09 2026 10:20:12.
The 52 wk high for Sandu Pharmaceuticals is 50.00 whereas the 52 wk low is 30.00
Sandu Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E:
- Sector P/E: -
- Dividend Yield: %
- D/E ratio: -
Sandu Pharmaceuticals reported a net profit of 1.77 Cr in 2026.
Quick Links
EQUITY QUICK LINKS
Sandu Pharmaceuticals QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.